{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:37:14Z","timestamp":1755801434335,"version":"3.44.0"},"posted":{"date-parts":[[2025,8,20]]},"group-title":"In Review","reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,2,24]]},"abstract":"<title>Abstract<\/title>\n        <p>Cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are muco-obstructive lung diseases. Knowledge of molecular processes has much improved therapeutic options in CF, whereas much less is known for COPD, a disease affecting an increasing number of patients. Here, we report a multilayer workflow integrating microbiome, inflammation and proteome profiling with clinical data to identify disease specific characteristics in sputum. Our proof-of-concept study shows that CF sputum is dominated by <italic>Pseudomonas<\/italic> and <italic>Staphylococcus<\/italic>, exhibits heightened neutrophilic inflammation, and a severe protease-antiprotease imbalance. In contrast, COPD displays heterogeneous microbiome composition, eosinophilic inflammation, and altered extracellular matrix remodeling. Proteome-based cellular deconvolution identifies disease-specific immune cell signatures, underscoring the complexity, especially in COPD. Multi-omics factor analysis establishes matrisome, and nucleotide metabolism changes as key disease discriminators. These findings highlight the potential of our integrated approach to uncover sputum biomarkers as tools for patient stratification and personalized therapeutic strategies in CF and COPD.<\/p>","DOI":"10.21203\/rs.3.rs-6095597\/v1","type":"posted-content","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T16:14:44Z","timestamp":1755706484000},"source":"Crossref","is-referenced-by-count":0,"title":["SputOMICs identifies common and distinct markers in cystic fibrosis and chronic obstructive pulmonary disease"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0499-2460","authenticated-orcid":false,"given":"Sebastien","family":"Boutin","sequence":"first","affiliation":[{"name":"Institute of Medical Microbiology, University of L\u00fcbeck and University Hospital Schleswig-Holstein, Campus L\u00fcbeck"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9572-9686","authenticated-orcid":false,"given":"Dario","family":"Frey","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Helm","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Guerra","sequence":"additional","affiliation":[{"name":"Department of Translational Pulmonology, University of Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hagner","sequence":"additional","affiliation":[{"name":"Department of Translational Pulmonology, University of Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-0746","authenticated-orcid":false,"given":"Junyan","family":"Lu","sequence":"additional","affiliation":[{"name":"Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-7513","authenticated-orcid":false,"given":"Susanne","family":"Dittrich","sequence":"additional","affiliation":[{"name":"ThoraxKlinik, University Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Wege","sequence":"additional","affiliation":[{"name":"ThoraxKlinik, University Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Eberhardt","sequence":"additional","affiliation":[{"name":"ThoraxKlinik, University Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Herth","sequence":"additional","affiliation":[{"name":"Thoraxklinik, University Hospital Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Sommerburg","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology & Allergology and Cystic Fibrosis Center, Department of Pediatrics, University of Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Schultz","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Dalpke","sequence":"additional","affiliation":[{"name":"University Hospital Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Klingmueller","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-2199","authenticated-orcid":false,"given":"Marcus","family":"Mall","sequence":"additional","affiliation":[{"name":"Charite\u0301 - Universit\u00e4tsmedizin Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMra1813799","article-title":"Muco-Obstructive Lung Diseases","volume":"380","author":"Boucher RC","year":"2019","unstructured":"Boucher RC (2019) Muco-Obstructive Lung Diseases. N Engl J Med 380:1941\u20131953","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41572-024-00538-6","article-title":"Cystic fibrosis","volume":"10","author":"Mall MA","year":"2024","unstructured":"Mall MA, Burgel PR, Castellani C, Davies JC, Salathe M, Taylor-Cousar JL (2024) Cystic fibrosis. Nat Rev Dis Primers 10:53","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(22)01273-9","article-title":"Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission","volume":"400","author":"Stolz D","year":"2022","unstructured":"Stolz D et al (2022) Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet 400:921\u2013972","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00239-2023","article-title":"Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary","volume":"61","author":"Agusti A","year":"2023","unstructured":"Agusti A et al (2023) Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J 61","journal-title":"Eur Respir J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis","volume":"402","author":"Taylor-Cousar JL","year":"2023","unstructured":"Taylor-Cousar JL, Robinson PD, Shteinberg M, Downey DG (2023) CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis. Lancet 402:1171\u20131184","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02029-2022","article-title":"Long-term safety and efficacy of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study","volume":"62","author":"Daines CL","year":"2023","unstructured":"Daines CL et al (2023) Long-term safety and efficacy of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study. Eur Respir J 62","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ppul.23190","article-title":"Five years of experience with biochemical cystic fibrosis newborn screening based on IRT\/PAP in Germany","volume":"50","author":"Sommerburg O","year":"2015","unstructured":"Sommerburg O et al (2015) Five years of experience with biochemical cystic fibrosis newborn screening based on IRT\/PAP in Germany. Pediatr Pulmonol 50:655\u2013664","journal-title":"Pediatr Pulmonol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0140-6736(23)01608-2","article-title":"The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches","volume":"402","author":"Graeber SY","year":"2023","unstructured":"Graeber SY, Mall MA (2023) The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches. Lancet 402:1185\u20131198","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2202153","DOI":"10.1183\/13993003.02153-2022","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis","volume":"62","author":"Schaupp L","year":"2023","unstructured":"Schaupp L et al (2023) Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis. Eur Respir J 62:2202153","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1513\/AnnalsATS.202008-1054OC","article-title":"Effects of Lumacaftor-Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic Fibrosis","volume":"18","author":"Graeber SY","year":"2021","unstructured":"Graeber SY et al (2021) Effects of Lumacaftor-Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic Fibrosis. Ann Am Thorac Soc 18:971\u2013980","journal-title":"Ann Am Thorac Soc"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","article-title":"International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study","volume":"370","author":"Buist AS","year":"2007","unstructured":"Buist AS et al (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370:741\u2013750","journal-title":"Lancet"},{"key":"ref12","first-page":"413","article-title":"The COPD Assessment Test: What Do We Know So Far? A Systematic Review and Meta-Analysis About Clinical Outcomes Prediction and Classification of Patients Into GOLD Stages","volume":"149","author":"Karloh M","year":"2016","unstructured":"Karloh M, Fleig Mayer A, Maurici R, Pizzichini MMM, Jones PW, Pizzichini E (2016) The COPD Assessment Test: What Do We Know So Far? A Systematic Review and Meta-Analysis About Clinical Outcomes Prediction and Classification of Patients Into GOLD Stages. Chest 149:413\u2013425","journal-title":"Chest"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00651-2019","article-title":"Airway inflammation in COPD: progress to precision medicine","volume":"54","author":"Brightling C","year":"2019","unstructured":"Brightling C, Greening N (2019) Airway inflammation in COPD: progress to precision medicine. Eur Respir J 54","journal-title":"Eur Respir J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/14789450.2017.1304215","article-title":"Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma","volume":"14","author":"Fujii K","year":"2017","unstructured":"Fujii K, Nakamura H, Nishimura T (2017) Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma. Expert Rev Proteom 14:373\u2013386","journal-title":"Expert Rev Proteom"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2147\/COPD.S308305","article-title":"A Proteomics-Based Analysis of Blood Biomarkers for the Diagnosis of COPD Acute Exacerbation","volume":"16","author":"Kim SH","year":"2021","unstructured":"Kim SH et al (2021) A Proteomics-Based Analysis of Blood Biomarkers for the Diagnosis of COPD Acute Exacerbation. Int J Chron Obstruct Pulmon Dis 16:1497\u20131508","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00082.2015","article-title":"Elevated sputum BPIFB1 levels in smokers with chronic obstructive pulmonary disease: a longitudinal study","volume":"309","author":"Gao J","year":"2015","unstructured":"Gao J et al (2015) Elevated sputum BPIFB1 levels in smokers with chronic obstructive pulmonary disease: a longitudinal study. Am J Physiol Lung Cell Mol Physiol 309:L17\u201326","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"L1155","DOI":"10.1152\/ajplung.00021.2016","article-title":"Lung tissue proteomics identifies elevated transglutaminase 2 levels in stable chronic obstructive pulmonary disease","volume":"310","author":"Ohlmeier S","year":"2016","unstructured":"Ohlmeier S et al (2016) Lung tissue proteomics identifies elevated transglutaminase 2 levels in stable chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 310:L1155\u20131165","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcf.2023.10.019","article-title":"Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis","volume":"23","author":"Maher RE","year":"2024","unstructured":"Maher RE et al (2024) Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis. J Cyst Fibros 23:269\u2013277","journal-title":"J Cyst Fibros"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn JS","year":"2016","unstructured":"Elborn JS (2016) Cystic fibrosis. Lancet 388:2519\u20132531","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1164\/rccm.201008-1285OC","article-title":"Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease","volume":"183","author":"Sapey E","year":"2011","unstructured":"Sapey E et al (2011) Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 183:1176\u20131186","journal-title":"Am J Respir Crit Care Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/s41564-022-01196-8","article-title":"Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions","volume":"7","author":"Yan Z","year":"2022","unstructured":"Yan Z et al (2022) Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions. Nat Microbiol 7:1361\u20131375","journal-title":"Nat Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.chom.2023.04.018","article-title":"Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease","volume":"31","author":"Liang W","year":"2023","unstructured":"Liang W et al (2023) Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease. Cell Host Microbe 31:1054\u20131070e1059","journal-title":"Cell Host Microbe"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e0116029","DOI":"10.1371\/journal.pone.0116029","article-title":"Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis","volume":"10","author":"Boutin S","year":"2015","unstructured":"Boutin S et al (2015) Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis. PLoS ONE 10:e0116029","journal-title":"PLoS ONE"},{"key":"ref24","first-page":"e62193","article-title":"Monitoring neutrophil elastase and cathepsin G activity in human sputum samples","author":"Frey DL","year":"2021","unstructured":"Frey DL, Guerra M, Mall MA, Schultz C (2021) Monitoring neutrophil elastase and cathepsin G activity in human sputum samples. JoVE (Journal Visualized Experiments), e62193","journal-title":"JoVE (Journal Visualized Experiments)"},{"key":"ref25","article-title":"Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis","volume":"13","author":"Frey DL","year":"2022","unstructured":"Frey DL et al (2022) Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis. Front Microbiol 13","journal-title":"Front Microbiol"},{"key":"ref26","article-title":"Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis","author":"Frey DL","year":"2021","unstructured":"Frey DL et al (2021) Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis. J Cyst Fibros","journal-title":"J Cyst Fibros"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01910-2017","article-title":"Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis","volume":"51","author":"Dittrich AS","year":"2018","unstructured":"Dittrich AS et al (2018) Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis. Eur Respir J 51","journal-title":"Eur Respir J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6258","DOI":"10.1002\/anie.201109226","article-title":"Spatially resolved monitoring of neutrophil elastase activity with ratiometric fluorescent reporters","volume":"51","author":"Gehrig S","year":"2012","unstructured":"Gehrig S, Mall MA, Schultz C (2012) Spatially resolved monitoring of neutrophil elastase activity with ratiometric fluorescent reporters. Angew Chem Int Ed 51:6258\u20136261","journal-title":"Angew Chem Int Ed"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02355-2019","article-title":"New method for rapid and dynamic quantification of elastase activity on sputum neutrophils from patients with cystic fibrosis using flow cytometry","volume":"55","author":"Hagner M","year":"2020","unstructured":"Hagner M et al (2020) New method for rapid and dynamic quantification of elastase activity on sputum neutrophils from patients with cystic fibrosis using flow cytometry. Eur Respir J 55","journal-title":"Eur Respir J"},{"key":"ref30","article-title":"MSPypeline: A python package for streamlined data analysis of mass spectrometry-based proteomics","author":"Heming S","year":"2022","unstructured":"Heming S et al (2022) MSPypeline: A python package for streamlined data analysis of mass spectrometry-based proteomics. Bioinf Adv","journal-title":"Bioinf Adv"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e8124","DOI":"10.15252\/msb.20178124","article-title":"Multi-Omics Factor Analysis\u2014a framework for unsupervised integration of multi-omics data sets","volume":"14","author":"Argelaguet R","year":"2018","unstructured":"Argelaguet R et al (2018) Multi-Omics Factor Analysis\u2014a framework for unsupervised integration of multi-omics data sets. Mol Syst Biol 14:e8124","journal-title":"Mol Syst Biol"},{"key":"ref32","article-title":"Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy","volume":"31","author":"Keir HR","year":"2022","unstructured":"Keir HR, Chalmers JD (2022) Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy. Eur Respiratory Rev 31","journal-title":"Eur Respiratory Rev"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiae153","article-title":"The relevance of eosinophils in chronic obstructive pulmonary disease: inflammation, microbiome and clinical outcomes","author":"Higham A","year":"2024","unstructured":"Higham A, Beech A, Singh D (2024) The relevance of eosinophils in chronic obstructive pulmonary disease: inflammation, microbiome and clinical outcomes. J Leukoc Biol","journal-title":"J Leukoc Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","article-title":"Eosinophils in COPD: just another biomarker?","volume":"5","author":"Bafadhel M","year":"2017","unstructured":"Bafadhel M, Pavord ID, Russell RE (2017) Eosinophils in COPD: just another biomarker? Lancet Respiratory Med 5:747\u2013759","journal-title":"Lancet Respiratory Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbrc.2022.07.025","article-title":"Rheology predicts sputum eosinophilia in patients with muco-obstructive lung diseases","volume":"622","author":"Volpato M","year":"2022","unstructured":"Volpato M et al (2022) Rheology predicts sputum eosinophilia in patients with muco-obstructive lung diseases. Biochem Biophys Res Commun 622:64\u201371","journal-title":"Biochem Biophys Res Commun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccm.2013.10.004","article-title":"Cellular and molecular mechanisms of chronic obstructive pulmonary disease","volume":"35","author":"Barnes PJ","year":"2014","unstructured":"Barnes PJ (2014) Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 35:71\u201386","journal-title":"Clin Chest Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/jlb.65.6.875","article-title":"Regulation of neutrophil FcgammaRIIIb (CD16) surface expression following delayed apoptosis in response to GM-CSF and sodium butyrate","volume":"65","author":"Moulding DA","year":"1999","unstructured":"Moulding DA, Hart CA, Edwards SW (1999) Regulation of neutrophil FcgammaRIIIb (CD16) surface expression following delayed apoptosis in response to GM-CSF and sodium butyrate. J Leukoc Biol 65:875\u2013882","journal-title":"J Leukoc Biol"},{"key":"ref38","article-title":"A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease","volume":"5","author":"Fenker DE","year":"2018","unstructured":"Fenker DE et al (2018) A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. Int J Respir Pulm Med 5","journal-title":"Int J Respir Pulm Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"101371","DOI":"10.1016\/j.xcrm.2023.101371","article-title":"Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies","volume":"5","author":"Cauwenberghs E","year":"2024","unstructured":"Cauwenberghs E et al (2024) Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies. Cell Rep Med 5:101371","journal-title":"Cell Rep Med"},{"issue":"Suppl 27","key":"ref40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/pai.13619","article-title":"Type 2 inflammation in cystic fibrosis: New insights","volume":"33","author":"Manti S","year":"2022","unstructured":"Manti S, Parisi GF, Papale M, Marseglia GL, Licari A, Leonardi S (2022) Type 2 inflammation in cystic fibrosis: New insights. Pediatr Allergy Immunol 33(Suppl 27):15\u201317","journal-title":"Pediatr Allergy Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.202310-1836OC","article-title":"Pharmacological Improvement of Cystic Fibrosis Transmembrane Conductance Regulator Function Rescues Airway Epithelial Homeostasis and Host Defense in Children with Cystic Fibrosis","volume":"209","author":"Loske J","year":"2024","unstructured":"Loske J et al (2024) Pharmacological Improvement of Cystic Fibrosis Transmembrane Conductance Regulator Function Rescues Airway Epithelial Homeostasis and Host Defense in Children with Cystic Fibrosis. Am J Respir Crit Care Med 209:1338\u20131350","journal-title":"Am J Respir Crit Care Med"},{"key":"ref42","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199111","article-title":"Automated sample preparation with SP 3 for low-input clinical proteomics","volume":"16","author":"M\u00fcller T","year":"2020","unstructured":"M\u00fcller T, Kalxdorf M, Longuesp\u00e9e R, Kazdal DN, Stenzinger A, Krijgsveld J (2020) Automated sample preparation with SP 3 for low-input clinical proteomics. Mol Syst Biol 16","journal-title":"Mol Syst Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jprot.2015.08.009","article-title":"Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects","volume":"128","author":"Titz B","year":"2015","unstructured":"Titz B et al (2015) Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects. J Proteom 128:306\u2013320","journal-title":"J Proteom"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.15252\/msb.20156123","article-title":"Time- and compartment\u2010resolved proteome profiling of the extracellular niche in lung injury and repair","volume":"11","author":"Schiller HB","year":"2015","unstructured":"Schiller HB et al (2015) Time- and compartment\u2010resolved proteome profiling of the extracellular niche in lung injury and repair. Mol Syst Biol 11:819","journal-title":"Mol Syst Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1038\/s41467-020-19015-1","article-title":"Benchmarking of cell type deconvolution pipelines for transcriptomics data","volume":"11","author":"Avila Cobos F","year":"2020","unstructured":"Avila Cobos F, Alquicira-Hernandez J, Powell JE, Mestdagh P, De Preter K (2020) Benchmarking of cell type deconvolution pipelines for transcriptomics data. Nat Commun 11:5650","journal-title":"Nat Commun"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6095597\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6095597\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T16:14:49Z","timestamp":1755706489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6095597\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":45,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6095597\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,8,20]]},"subtype":"preprint"}}